Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis

Published:2021-01-01 Issue:1 Volume:28 Page:2534-2547
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Zhang Ya-Wen¹,Tu Ling-Lan²,Zhang Yi¹,Pan Jie-Chao³,Zheng Gao-Li⁴,Yin Li-Na¹

Affiliation:

1. Institute of Materia Medica, Hangzhou Medical College, Hangzhou, China

2. School of Biological Engineering, Hangzhou Medical College, Hangzhou, China

3. Hangzhou Xianju Technology Innovation Co. Ltd, Hangzhou, China

4. Safety Evaluation Research Center, Hangzhou Medical College, Hangzhou, China

Funder

Medical and Health Technology Project of Zhejiang Province, China

Special Project of Zhejiang Academy of Medical Sciences

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/10717544.2021.2008054

Reference37 articles.

1. An algorithm for the grading of activity in chronic hepatitis C

2. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects

3. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt

4. Synthesis of a novel polymer bile salts-(polyethylene glycol)2000-bile salts and its application to the liver-selective targeting of liposomal DDB

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated oral microgel system ameliorates renal fibrosis by hitchhiking co-delivery and targeted gut flora modulation;Journal of Nanobiotechnology;2024-06-01

2. Asiatic acid cyclodextrin inclusion micro-cocrystal for insoluble drug delivery and acute lung injury therapy enhancement;Journal of Nanobiotechnology;2024-03-17

3. Recent insights into therapeutic potential and nanostructured carrier systems of Centella asiatica: An evidence-based review;Pharmacological Research - Modern Chinese Medicine;2024-03

4. A Detailed Insight into Nanostructured Lipid Carriers: A Versatile Drug Delivery System;Recent Patents on Nanotechnology;2023-12

5. Isovitexin alleviates hepatic fibrosis by regulating miR-21-mediated PI3K/Akt signaling and glutathione metabolic pathway: based on transcriptomics and metabolomics;Phytomedicine;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3